Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$138M |
| 3 |
NVIDIA
NVDA
|
+$83.1M |
| 4 |
Johnson & Johnson
JNJ
|
+$60.1M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$56.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI India ETF
INDA
|
+$130M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$118M |
| 3 |
Apple
AAPL
|
+$98.7M |
| 4 |
Sherwin-Williams
SHW
|
+$97.9M |
| 5 |
CSX Corp
CSX
|
+$91.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.73% |
| 2 | Technology | 10.28% |
| 3 | Healthcare | 7.87% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Financials | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Amylyx Pharmaceuticals
AMLX
$4.14B
| $539K | ﹤0.01% |
166,429
+144,829
| +671% | +$326K |
|
1402
Xenon Pharmaceuticals
XENE
$5.88B
| $535K | ﹤0.01% |
13,582
-18,678
| -58% | -$753K |
|
|
AZPN
1403
DELISTED
Aspen Technology Inc
AZPN
| $534K | ﹤0.01% |
2,237
+853
| +62% | +$179K |
|
|
DNB
1404
DELISTED
Dun & Bradstreet
DNB
| $532K | ﹤0.01% |
46,239
-66,098
| -59% | -$734K |
|
1405
CTS Corp
CTS
$1.61B
| $532K | ﹤0.01% |
10,997
+5,341
| +94% | +$259K |
|
1406
Tennant Co
TNC
$1.19B
| $531K | ﹤0.01% |
5,530
+2,340
| +73% | +$228K |
|
1407
Veracyte
VCYT
$3.49B
| $531K | ﹤0.01% |
15,599
-31,195
| -67% | -$878K |
|
1408
Coca-Cola Femsa
KOF
$24.4B
| $529K | ﹤0.01% |
+5,967
| New | +$521K |
|
1409
Pathward Financial
CASH
$1.75B
| $526K | ﹤0.01% |
7,970
-1,520
| -16% | -$97.7K |
|
1410
Bunge Global
BG
$21.3B
| $523K | ﹤0.01% |
+5,416
| New | +$554K |
|
1411
Medpace
MEDP
$17.1B
| $523K | ﹤0.01% |
1,568
-1,750
| -53% | -$665K |
|
1412
Dutch Bros
BROS
$7.07B
| $521K | ﹤0.01% |
16,272
-111,544
| -87% | -$3.93M |
|
1413
XPeng
XPEV
$11B
| $520K | ﹤0.01% |
+42,702
| New | +$354K |
|
|
RVNC
1414
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $519K | ﹤0.01% |
+100,000
| New | +$497K |
|
1415
Payoneer
PAYO
$2.41B
| $516K | ﹤0.01% |
68,581
-47,090
| -41% | -$306K |
|
1416
Lamar Advertising Co
LAMR
$15.5B
| $516K | ﹤0.01% |
+3,859
| New | +$471K |
|
1417
iShares US Transportation ETF
IYT
$2.28B
| $514K | ﹤0.01% |
+7,456
| New | +$491K |
|
1418
KB Home
KBH
$3.42B
| $513K | ﹤0.01% |
+5,990
| New | +$482K |
|
|
DX
1419
Dynex Capital
DX
$3.22B
| $513K | ﹤0.01% |
40,200
-775,148
| -95% | -$9.57M |
|
1420
DTE Energy
DTE
$28.3B
| $512K | ﹤0.01% |
3,984
+1,724
| +76% | +$208K |
|
|
HTO
1421
H2O America
HTO
$2.67B
| $509K | ﹤0.01% |
+8,751
| New | +$512K |
|
1422
ABM Industries
ABM
$2.73B
| $508K | ﹤0.01% |
9,630
-11,111
| -54% | -$588K |
|
1423
CAVA Group
CAVA
$8.2B
| $508K | ﹤0.01% |
+4,100
| New | +$417K |
|
1424
Teladoc Health
TDOC
$1.12B
| $507K | ﹤0.01% |
55,185
-64,376
| -54% | -$533K |
|
|
LBPH
1425
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $505K | ﹤0.01% |
15,158
-81,167
| -84% | -$2.79M |
|
Similar funds
Steve Schonfeld's Q3 2024 Portfolio in Review
As of Q3 2024, Steve Schonfeld held 2,574 positions worth $15B, down 3.3% from $15.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Steve Schonfeld withdrew a net $1.49B in Q3 2024, closing 586 positions and reducing 825 holdings. Its most notable exit was Rogers Communications, an estimated $47.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Steve Schonfeld opened a new position in iShares MSCI Emerging Markets ETF worth $60.2M.
- Steve Schonfeld's largest Q3 2024 buy was iShares MSCI Emerging Markets ETF: 1,312,275 shares worth $60.2M.
- Steve Schonfeld added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $1.11B increase.
- Steve Schonfeld's biggest Q3 2024 reduction was iShares MSCI India ETF, cutting an estimated $130M.
- Steve Schonfeld fully exited Rogers Communications in Q3 2024, selling an estimated $47.5M.
- Steve Schonfeld's ten largest holdings make up 32% of its $15B portfolio in Q3 2024.
- Steve Schonfeld opened 477 new positions and closed 586 in Q3 2024.
- Steve Schonfeld's portfolio value fell 3.3% quarter-over-quarter to $15B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.